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Abstract
Background: Access to sterile syringes is a proven means of reducing the transmission of human
immunodeficiency virus (HIV), viral hepatitis, and bacterial infections among injection drug users.
In many U.S. states and territories, drug paraphernalia and syringe prescription laws are barriers to
syringe access for injection drug users (IDUs): pharmacists may be reluctant to sell syringes to
suspected IDUs, and police may confiscate syringes or arrest IDUs who cannot demonstrate a
"legitimate" medical need for the syringes they possess. These barriers can be addressed by
physician prescription of syringes. This study evaluates physicians' willingness to prescribe syringes,
using the theory of planned behavior to identify key behavioral influences.
Methods: We mailed a survey to a representative sample of physicians from the American Medical
Association physician database. Non-responding physicians were then called, faxed, or re-sent the
survey, up to four times.
Results: Twenty percent responded to the survey. Although less than 1 percent of respondents
had ever prescribed syringes to a known injection drug user, more than 60% of respondents
reported that they would be willing to do so. Physicians' willingness to prescribe syringes was best
predicted by the belief that it was a feasible and effective intervention, but individual and peer
attitudes were also significant.
Conclusion: This was the first nationwide survey of the physician willingness to prescribe syringes
to IDUs. While the majority of respondents were willing to consider syringe prescription in their
clinical practices, multiple challenges need to be addressed in order to improve physician
knowledge and attitudes toward IDUs.
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Background
"Because physicians are key gatekeepers to syringe access,
efforts to encourage them to prescribe syringes to [Injec-
tion Drug Users] will help ensure that those who continue
to inject can legally obtain sterile syringes. Involving phy-
sicians also illustrates the medical rationale for increasing
IDUs' access – that improving access to sterile syringes has
a legitimate medical purpose in preventing disease."[1]
Providing safe injection equipment to people who inject
illicit drugs reduces the risk of transmission of the human
immunodeficiency virus (HIV) and hepatitis C virus
(HCV) and can encourage users to enter substance abuse
treatment.[2] Data collected from the National Health
and Nutrition Examination Survey from 1999–2001
found that of individuals reporting injection drug use in
the past year, 47.1% purchased their last syringe at a phar-
macy, 21.5% obtained the syringe privately from some-
one else, 8.7% bought their injection equipment on the
street, 3.6% acquired it from a needle exchange, and the
remaining obtained syringes at a shooting gallery or from
a drug dealer.[3]
Laws and the attitudes of pharmacists and police officers
continue to make it harder for IDUs to purchase or carry
sterile syringes in many places. Only three states now
require a prescription for all retail syringe purchases, but
most states have drug paraphernalia laws or pharmacy
regulations that may make pharmacists less willing to sell
syringes to IDUs, and expose IDUs to police interference
or arrest if they cannot demonstrate a legal basis for pos-
sessing syringes. [4-8]
Health care providers of IDUs are in a unique position to
improve syringe access and increase sterile injection prac-
tices. [9,10] Physicians can legally prescribe syringes to
IDU patients in most states. Even in locations where it is
not legally required a medical prescription for obtaining a
syringe may make it easier for IDUs to buy syringes in
pharmacies and to avoid arrest or confiscation of syringes
by the police. A pilot syringe prescription program among
327 IDUs in Rhode Island provided participants with
basic clinical exams, medical care, hepatitis A and B
immunizations, and links to substance abuse treatment.
Notably, patients reported correct disposal in biohazard
containers and decline in some drug-using behaviors. [11]
Physicians who prescribe syringes can also effectively
engage patients in conversations on drug use and drug
treatment. Physician counsel can be a powerful influence
on safe injection practices. [9-13]
Small-scale surveys conducted in Rhode Island and
among addiction medicine specialists reported that a
majority of physicians were receptive to the idea of pre-
scribing syringes to IDUs. [13,14] The American Medical
Association, Infectious Diseases Society of America, Amer-
ican Public Health Association, the Centers for Disease
Control, and other professional and public health organ-
izations have supported syringe prescription in conjunc-
tion with drug treatment education and counseling for
IDUs. [1]
Much stands in the way, however, of the public health
gains that would be made possible by physicians prescrib-
ing syringes. Barriers to syringe prescription could include
the following: the stigma attached to drug use by physi-
cians, lack of formal medical education about drug treat-
ment options, lack of local availability of drug treatment
and other interventions, time and financial pressures, pro-
fessional traditions, fears that the patient base may disap-
prove of physicians who provide care to IDUs, and mutual
mistrust between physicians and their drug using patients.
[10,15,16]
This study was undertaken to assess physicians' willing-
ness to prescribe syringes to IDU patients and to under-
stand the barriers and facilitators to physician
participation in such programs. We use the theory of
planned behavior to identify factors influencing willing-
ness to prescribe syringes, and offer recommendations for
action to promote better health care for IDUs.
Methods
Study Sample
The study population was selected from all registered phy-
sician members of the American Medical Association
(AMA), which includes physicians from all fifty states and
Puerto Rico. We chose the study population from among
physicians who either provided direct patient care or prac-
ticed in specialties that were likely to treat patients who
could be injection drug users, including practitioners in
the following categories: Primary care providers (Internal
Medicine, Family Practice, General Practice, Gynecology);
2) Pediatric/adolescent medical providers; 3) Emergency
room physicians; and 4) Specialists (Addiction Medicine,
Addiction Psychiatry, Endocrinology, Diabetes and
Metabolism, Infectious Disease, Obstetrics, Physical Med-
icine, Rehabilitation, and Pain Medicine). The AMA data-
base has basic demographic information including
gender, race, age, geographic location, and date of medical
school graduation.
Physician Data Collection
A four-page, 46-question survey was mailed to our study
sample, including a cover letter describing the study and
noting the sponsorship of the Centers for Disease Control
and Prevention (CDC), the AMA, Brown Medical School,
and Temple University Law School. Physicians were
informed that their responses would be kept confidential,
and consent was confirmed by the completion and sub-Substance Abuse Treatment, Prevention, and Policy 2009, 4:13 http://www.substanceabusepolicy.com/content/4/1/13
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mission of the survey. All mailings included a self-
addressed return envelope with postage included. Up to
four mailings were sent out to each participant, until a
response was obtained. The first, second, and third mail-
ings were sent by first class mail. The fourth mailing was
sent by FedEx 2-day delivery. Concurrently, to increase
response rate, we called physicians with available phone
numbers. Physicians were asked if they had received a
copy of the survey and, if not, we asked if we could fax
them another copy. Up to 3 faxes were sent to each physi-
cian, up to three weeks after the initial mailing. The survey
consisted of 17 multiple-choice questions and 28 agree-
ment-items with a 5-point Likert scale response choice
("strongly agree" to "strongly disagree"). The multiple
choice questions covered a range of subjects, including
whether physicians treated IDUs in their practices, and
physicians' knowledge, attitudes, and practices related to
syringe access, overdose reversal, and other harm-reduc-
tion interventions associated with injection drug use. The
data were double entered for accuracy and analyzed using
SAS software. All protocols were reviewed by The Miriam
Hospital and Temple University Institutional Review
Boards (IRBs).
Analysis
Odds ratios (ORs) are presented to describe demographic
differences between responses and non-responses. We
also described overall frequencies of responses on survey
questions. We then focused on the outcome measure,
which was a positive response to the question, "Would you
consider prescribing syringes/needles to an IDU as part of an
effort to prevent the spread of blood-borne disease?" We con-
ducted bivariate comparisons of physicians who were
willing and those who were not, by other variables, using
odds ratios and 95% confidence intervals. Multivariate
logistic regression was used to determine which variables
were most associated with willingness to prescribe, and
were reported as adjusted OR's.
The theory of planned behavior (TPB) is a socio-psycho-
logical model that has been successfully employed to
assess and predict physician behavior. [17-19] The TPB
posits that the intention to engage in a given behavior is a
strong predictor of actual behavior, and that intention can
be measured as a function of three characteristics of the
actor: attitudes towards the behavior, beliefs about the
ability to successfully perform the behavior and achieve
the desired outcome (perceived control), and perception
of peer attitudes towards the behavior (subjective norms).
[20] In our analysis, the model holds that physicians' will-
ingness to prescribe syringes to drug-using patients is a
function of 1) their attitudes toward syringe prescription;
2) whether it would be feasible and useful for them to pre-
scribe syringes (perceived control); and 3) how their col-
leagues and patients would react to the behavior
(subjective norms). To perform the TPB analysis, eleven of
the Likert-scaled agreement items were assigned by inves-
tigator consensus to one of three categories: 1) Attitudes,
2) Perceived Control, or 3) Subjective Norms. Questions
included in each category are listed in Table 1. Analysis
included using alpha-reliability coefficients for scale
development and summary. Individual items were
rescaled to 0–100 and then averaged to create final com-
posite scales. Logistic regression models were used to eval-
uate the magnitude of associations between willingness to
prescribe and TPB domains.
Table 1: Variables included in Theory of Planned Behavior Model
Attitudes:
- Prescribing sterile syringes is an important tool in stopping the spread
of blood-borne disease among IDUs
- Malpractice insurance should be higher for MDs who prescribe syringes
- It is right to disobey the law for a compelling reason such as preventing an IDU from getting or transmitting HIV
Perceived Control
- No one would ever find out if I prescribed syringes to my IDU patients
- IDUs will use sterile needles if they are made readily available
- There is a legitimate medical reason for IDUs to obtain sterile syringes
- I help the community by prescribing syringes to IDUs
Subjective Norms
- I would feel embarrassed justifying prescribing syringes
- My colleagues believe you should obey law even if you disagree
- People whose opinions I respect would approve of my bending the rules to prevent HIV among
my drug-using patients
- Colleagues whose judgment matters to me would disapprove of my providing syringes to IDUSubstance Abuse Treatment, Prevention, and Policy 2009, 4:13 http://www.substanceabusepolicy.com/content/4/1/13
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Results
Our study sample included a 1.5% (3435) geographically
representative sample of AMA master file physicians from
four major groups: Primary Care, Pediatrics, Emergency
Medicine, and Specialists. One hundred forty-six (4.3%)
individuals from our sample were either deceased or
retired and 442 (12.8%) were unreachable because of
incorrect contact information. This left 2847 eligible phy-
sicians for our study. Two hundred eighty-eight physicians
(10.1%) refused to participate, while 69.2% (n = 1971)
were non-responders. Thus, a total of 588 (20.6% of eligi-
ble) physicians responded to the survey. Two hundred
sixty-six physicians (9.3%) responded after the 1st mail-
ing. Telephone numbers were available for 1636 physi-
cians, (57%) of whom were faxed the questionnaire; 199
(7.0%) responded. An additional 4.3% responded after
the 2nd (n = 64) and 3rd (n = 59) mailing.
Demographic characteristics of the responders compared
to the non-responders can be found in Table 2. Respond-
ers were more likely to be white, female, younger, and less
likely to be a primary care physician. No significant differ-
ences were found between responders and non-respond-
ers regarding region of residence in the United States or
the nature of laws pertaining to syringe acquisition in
their state.
Responses to questions related to IDUs in physicians'
practices, as well as physicians' knowledge, attitudes, and
practices related to drug users are found in Table 3. Forty
percent reported having IDUs in their practice, but only
28% reported that they always raise the issue of drug use
when reviewing a patient's medical history. Forty-seven
percent reported that they would consider prescribing
syringes to drug-injecting patients, though only 6 physi-
cians reported they had actually done so without any
other indication of medical need other than injection
drug use, such as diabetes. Few (7.4%) reported knowing
of other physicians who prescribed syringes. Most (79%)
respondents did not report knowing whether prescribing
syringes was legal in their state. Over 90% attributed the
sharing of syringes among IDUs to barriers to access, but
most also responded that the behavior was attributable to
the influence of "the drug culture" and lack of informa-
tion. When asked about syringe availability in their home
state, either through needle exchange programs (NEP), or
over the counter (OTC) pharmacy sales, the majority
(>50% across all categories of respondents) reported
"don't know" (data not shown).
Physicians willing to prescribe syringes were similar to
others in gender, age, year of graduation, and specialty.
Geographical differences were more pronounced, how-
Table 2: Demographic data comparing respondents to non-respondents (N = 3435)
Respondents
(N = 588)
Non-Respondents (N = 1971) Chi-square
p-value
Gender
Female 29.8% (175) 24.9% (491) 0.01
Age (mean ± std)
Age: 49.3 ± 11.2 51.1 ± 12.4 0.0009
Specialty
Primary 81.3% (478) 85.6% (1687) 0.0001
Emergency Medicine 12.9% (76) 8.3% (164)
Specialist 5.8% (34) 6.1% (120)
Region
Northeast 26.2% (152) 24.7% (487) 0.75
South 26.7% (155) 28.8% (568)
Midwest 23.2% (135) 23.1% (455)
West 23.9% (139) 23.4% (461)
Homestate syringe law
Strict Prohibition 27.0% (149) 30.4% (599) 0.12
Access Intermediate 40.1% (221) 40.6% (800)
Open access syringe sales 32.8% (181) 29.0% (572)
Syringe Exchange Program
Legal SEP 52.8% (309) 50.0% (986) 0.12
SEP w/o claim to legal 27.2% (159) 26.1% (514)
No SEP operating 20.0% (117) 23.9% (471)Substance Abuse Treatment, Prevention, and Policy 2009, 4:13 http://www.substanceabusepolicy.com/content/4/1/13
Page 5 of 9
(page number not for citation purposes)
ever, with those practicing in the South and Midwest
being less likely to consider prescribing than those work-
ing in the West and Northeast (Table 4). Physicians who
reported having IDUs in their practice were 1.5 times
(95% CI: 1.02–2.29) more likely to consider prescribing
syringes and 2.9 times (95% CI: 1.13–7.39) more likely if
they asked their patients about syringe sharing. The
strongest predictor of being willing to prescribe was the
physician's belief that IDUs share because they do not
have access to sterile syringes, both in the univariate and
multivariate model (OR 4.6; 95% CI 2.0–10.9 and AOR
4.75; 95% CI 2.0–11.4 respectively). Physicians who
reported knowing how/where syringes were legally avail-
able to IDUs in their area were significantly more likely to
be willing to prescribe syringes than those who did not
know or who believed there was no legal access. This held
true both in univariate and multivariate analyses. Willing-
ness to prescribe syringes was significantly associated with
having prescribed syringes to a person with diabetes who
might be an IDU (OR, 2.8; 95% CI, 1.3–6.2) and knowing
someone who prescribes syringes to IDUs (OR, 3.8; 95%
CI, 1.5–10.1); although in the final model, prescribing
syringes to an IDU person with diabetes was marginally
significant (i.e., included 1.0 in the confidence interval
(AOR, 2.3; 95% CI, 1.0–5.2)).
Table 5 presents the results from TPB analyses. Willing-
ness to prescribe syringes was significantly associated with
each of the theory of planned behavior domains, with per-
ceived control being the strongest predictor, both alone
(OR = 2.9; CI: 2.4–3.7) and in the final model (OR = 2.0;
CI: 2.0–2.5). Attitudes towards care for IDUs and percep-
tions of peer attitudes were also robust predictors of phy-
sician willingness to participate in syringe prescription
programs. Physicians who regarded prescribing as an
important tool for preventing HIV, and those who felt
strongly enough to approve of "civil disobedience" if the
practice were illegal, were more likely to be willing to con-
sider prescribing than those who did not. Conversely,
those who would be embarrassed about prescribing, and
who felt their peers would disapprove of prescribing or
breaking the law, were less likely to be willing to partici-
pate in such programs.
Discussion
Drug users in need of drug use-related care regularly seek
primary care services and specialty care throughout the
nation. For IDUs who are not currently willing to enter
addiction treatment, two of the most pressing medical
needs are access to sterile injection equipment and assist-
ance in adopting sterile injection practices. Their regular
health care providers can and should take steps to encour-
age treatment and help them minimize the harms of
ongoing injection drug use.
This is the first national survey of physicians' attitudes and
behaviors related to prescribing syringes to IDU patients
to prevent the spread of disease. Our data are similar to
prior findings that physicians, despite never actually hav-
ing prescribed syringes to IDUs, would consider doing so.
[13-15] This study highlights that physician syringe pre-
scription is an acceptable practice for many practitioners
Table 3: Univariate responses to survey questions
Total Yes No Don't know
n n (%) n (%) n (%)
Do you have injection drug users (IDUs) as patients in your practice? 571 232 40.6% 339 59.4% - -
Is it legal in your state to prescribe syringes? 572 40 70.0% 82 14.3% 450 78.7%
Would you consider prescribing syringes as part of an effort to prevent blood-borne pathogens? 568 267 47.0% 160 28.2% 141 24.8%
Do you know other MDs who prescribe syringes? 571 42 7.40% 529 92.6% - -
Why do you think IDUs share needles?
They don't know any better 509 278 54.6% 231 45.4%
It is part of the drug culture 531 441 83.1% 90 16.9%
They don't have access to enough syringes 537 505 94.0% 32 6.0%
Lack of money 530 478 90.2% 52 9.8%
Fear of going to a needle exchange facility 503 395 78.5% 108 21.5%
Do you raise the issue of drug use when reviewing a patient's medical status or history? 417 98.1% 8 1.9%
Do you ask your patients about their use of individual illegal drugs? 554 96.3% 21 3.7%
Have you ever prescribed syringes to diabetic patients that you knew or suspected would use 
them to inject illegal drugs
57 10.1% 509 98.9%
Have you ever prescribed syringes to patient with no other indication that you suspected would 
use them to inject illegal drugs to prevent spread of disease?
19 3.4% 546 96.6%Substance Abuse Treatment, Prevention, and Policy 2009, 4:13 http://www.substanceabusepolicy.com/content/4/1/13
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Table 4: Bivariate and multivariate analyses comparing physicians willing to prescribe syringes by other variables




Female 64% 125 1.09 0.7–1.7
Male 62% 302
Specialty
Not Primary (85) 64% 54 1.1 0.7–1.7
Primary (342) 62% 213
Region
Northeast (115) 70% 81 0.9 0.5–1.6
South (110) 54% 59 0.4* 0.2–0.8
Midwest (102) 54% 55 0.4* 0.2–0.8
West (95) 73% 69
Syringe status
Strict prohibition (103) 69% 71 1.65 1.0–2.8
Open access syringe sales (142) 65% 92 1.37 0.9–2.2
Intermediate Access (157) 57% 89
SEP status
Legal Sep (230) 67% 154 1.6 0.9–2.7
SEP w/o claim to legal (116) 59% 68 1.1 0.6–2.0
No SEP operating (79) 56% 44
IDUs in practice
Yes (181) 68% 123 1.5* 1.0–2.3
No (239) 58% 137
Ask IDUs about sharing needles
Yes (168) 70% 118 2.9* 1.1–7.4
No (20) 45% 9
IDUs share because they don't have sterile syringes
Yes (373) 65% 242 4.6* 2.0–10.9 4.8* 2.0–11.4
No (26) 45% 12
IDUs share because they do not have money
Yes (352) 65% 229 2.3* 1.2–4.3
No (44) 45% 20
Awareness of access syringe exchange in location of practice
Yes (104) 71% 74 1.6 1.0–2.6
No (91) 63% 57
Don't know (226) 58% 131
Awareness of over-the-counter pharmacy syringe sales
Yes (72) 74% 53 1.8 1.0–3.2
No (100) 65% 65
Don't know (247) 59% 146
Awareness of syringe prescription by physician
Yes (115) 72% 83 1.8* 1.1–2.9 1.8* 1.1–2.9
No (94) 59% 55
Don't know (211) 59% 124
Syringe prescription is legal
Yes (36) 83% 30 1.3 0.8–2.1
No (390) 61% 238
Ever prescribed to IDU with Diabetes
Yes (42) 81% 34 2.8* 1.3–6.2 2.3 1.0–5.2
No (380) 60% 228
Ever prescribe to IDU w/o indication
Yes (15) 80% 12 2.5 0.7–9.1
No (406) 60% 244
Know another MD who prescribes to IDU
Yes (34) 85% 29 3.8* 1.5–10.1
No (390) 60% 234
*Significant based on 95% CIsSubstance Abuse Treatment, Prevention, and Policy 2009, 4:13 http://www.substanceabusepolicy.com/content/4/1/13
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sampled in this nationwide survey. More importantly, the
findings tie syringe prescription to a range of good prac-
tices and favorable attitudes in the treatment of addiction
in the course of regular medical care: willingness to pre-
scribe syringes was strongly associated with speaking to
patients about drug use and about syringe sharing, and
being aware of the problem of syringe access in the area.
The Theory of Planned Behavior model that we used to
identify factors influencing physician prescription of
syringes suggests a number of steps that would increase
physician willingness to prescribe syringes. Providing
physicians with the information that prescribing syringes
can benefit patients and community health might impact
attitudes and greater perceived behavioral control of phy-
sicians in adopting syringe prescription practices. The law
governing syringe possession and prescription was a fac-
tor in perceived behavioral control and subjective norms.
Physicians will be more likely to prescribe syringes if they
know that doing so is legal. Steps by public health agen-
cies, professional bodies, and regulatory authorities to
educate physicians that prescribing syringes is a legitimate
medical practice [1,11] would promote providers' willing-
ness to participate in syringe prescription programs. More-
over, given that our data showed physician willingness to
prescribe was influenced by knowledge of their patients'
drug using behavior, interventions directed toward stand-
ardizing physician knowledge of drug use practices may
also improve their willingness to prescribe syringes.
The primary limitation of this study is the low response
rate of 20.6% in our sample despite multiple, intensive
inquiries. National physician surveys whose methodology
we adopted and implemented in this study reported
response rates between 44–65%, [21-23] however, physi-
cian surveys on topics related to substance abuse and
injection drug use in particular have tended to have lower
response rates. [24-26] Unfortunately, based on the low
response rate, results are not generalizable to physicians
in general, or to physicians who work in the subspecialties
we sampled from. What is compelling about the data is
that among physicians that may have a commitment to
substance using patients that did  respond, this study
reveals a fundamental lack of knowledge about the culture
of IDUs and their behaviors, as well as state syringe pre-
scription laws.
How physicians, individually and as a profession, regard
drug users is also an important factor in their willingness
to prescribe. The statements of major medical associations
in support of prescribing syringes are of immediate
importance in these domains. More generally, primary
and continuing medical education across all specialties is
a key venue for addressing the stigma of drug use and its
negative impact on patient and community health. To
influence physicians earlier in the pipeline, providing sub-
stance use and addiction research as part of medical
school education could formally present addiction as a
clinical condition as opposed to having their first encoun-
ter with drug use be during an Emergency Department
clinical rotation. Through a better understanding of the
physiology of addiction, providers can be better equipped
to define treatment goals and outcome measures, which
include options other than simple abstinence. Given that
IDUs tend to seek health care in later stages of adverse
health outcomes and are more likely to receive care in the
emergency room as opposed to a clinic, targeted training
for certain physicians (e.g., emergency department physi-
cians) based on their potential interaction with IDUs may
increase the likely impact on drug using populations.
Conclusion
Physicians within their medical practice have an impor-
tant opportunity to intervene in substance abuse behavior





unadj OR 95% CI adj OR* 95% CI
Measures n % n % (n = 425 for model)
Attitude Scale (3 item) 2.45 2.05–2.94 1.81 1.47–2.22
> = 50 200 75.2% 33 20.6% (chisq = 31.9)
<50 66 24.8% 127 79.4%
2.24 1.87–2.70 1.53 1.23 – 1.89
Subjective Norms Scale (4 item)
= 50 203 76.6% 56 35.0% (chisq = 14.7)
<50 62 23.4% 104 65.0%
2.93 2.36–3.65 2.00 1.59 – 2.51
Perceived Control Scale (4 item)
> = 50 206 77.7% 33 20.6% (chisq = 35.4)
<50 59 22.3% 127 79.4%
*odds ratio and 95% CI are for a 10 point increase in the scale
ROC for model = .902Substance Abuse Treatment, Prevention, and Policy 2009, 4:13 http://www.substanceabusepolicy.com/content/4/1/13
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on an individual level. Prescribing syringes to IDUs
should figure among such interventions because it can
help prevent the transmission of bloodborne disease and
enhance overall IDU care. The physicians in our study
were generally amenable to participating in syringe pre-
scription programs, but physician willingness to act can
be supported by better communication of what consti-
tutes evidence-based practice, alleviation of legal con-
cerns, and explicit validation by peers and professional
organizations. Requiring substance abuse as a subject in
medical training and continuing medical education
would also promote better care for IDUs. Interventions
that seek to address physician attitudes toward IDUs and
provide state-of-the-art knowledge on the physiology of
addiction could be the first step to garnering attention and
renewed focus to the need to optimize IDU health care.
Other strategies to improve physician knowledge include
mandatory substance abuse training in medical school
and continuing medical education programs which pro-
mote better care for IDUs.
The success of the IDU care programs established to date
demonstrates that even a few committed physicians can
make a big difference, but IDU care will remain sub-opti-
mal–and public health will suffer–unless more physicians
understand and implement harm-reduction intervention
strategies like syringe prescription.
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